SCHEMBL5862261

SCHEMBL5862261

NC(=O)N(c1ccc(Oc2ccccc2)cc1)c1ccc2cn(CCCN3CCOCC3)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
SCN9A Q15858 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HPGD P15428 2/20 0.39
TACR2 P21452 4/20 0.39
LCK P06239 2/20 0.38
EPHX2 P34913 2/20 0.38
MAPT P10636 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5860521 0.83 MCHR1 (0.42) MCHR1ALDH1A1MEN1KMT2A
SCHEMBL5860855 0.81 ALDH1A1 (0.41) MCHR1ALDH1A1SCN9A
SCHEMBL5862060 0.81 MCHR1 (0.67) MCHR1ALDH1A1HPGDTACR2EPHX2
SCHEMBL6380408 0.80 MCHR1 (0.64) MCHR1ALDH1A1SCN9AHDAC3HDAC1
SCHEMBL5860936 0.80 MCHR1 (0.41) MCHR1ALDH1A1KDM4EGAA
SCHEMBL6348132 0.78 MCHR1 (0.45) MCHR1ALDH1A1LMNAKDM4EMEN1
SCHEMBL6374843 0.77 NPSR1 (0.45) MCHR1ALDH1A1LMNAHPGDL3MBTL1
SCHEMBL5860819 0.75 MCHR1 (0.68) MCHR1ALDH1A1LMNATP53SCN9A
SCHEMBL5862087 0.72 MCHR1 (0.65) MCHR1ALDH1A1HPGDTACR2EPHX2
SCHEMBL5862042 0.72 MCHR1 (0.76) MCHR1MAPTKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 US claimed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885ALDH1A1 2303/4885LMNA 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.